Transforming clinical trials through CRO-ePRO partnerships
This article was originally published in SRA
Executive Summary
Gregg Jewett explains why recent trends in the biopharmaceutical market make a CRO-ePRO alliance so valuable to industry.
You may also be interested in...
Digital Health Roundup, January/February 2021: The Continued Rise Of AI, Telehealth
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
US Regulatory Roundup, February 2021: QA/RA Predictions, FDA Warning Letter Stats, PMA Case Study, And More
Quality and regulatory predictions for 2021, a count of 2020 US FDA enforcement missives, a premarket approval case study for a novel prosthetic, and more topped our list of most-read Medtech Insight articles in February.
Too Small A Company To Interest US Plaintiffs’ Class Action Bar? Think Again, Attorney Says
Locke Lord senior counsel Sharon Blinkoff shares perspective from her experience defending smaller cosmetics companies against US class action plaintiff demands and litigation.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: